Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNA guanine 2-amino group, also known as the N2 position, is a nucleophilic site located within the minor groove of the DNA double helix (Tomasz, 1995). While guanine is a fundamental building block of genetic material, its 2-amino group is specifically targeted by a class of anti-tumor agents known as minor groove alkylators, including the marine-derived compound trabectedin and its synthetic derivative lurbinectedin (Markham, 2020). Unlike many DNA-damaging agents that target the major groove or the N7 position of guanine, drugs targeting the N2-amino group form stable covalent adducts that distort the DNA architecture by bending it toward the major groove (D'Incalci & Galmarini, 2010). This structural distortion interferes with the recruitment of transcription factors and the processing of DNA by various enzymes. Crucially, the presence of these adducts triggers a unique 'poisoning' effect on the nucleotide excision repair (NER) system; instead of repairing the damage, the NER machinery is recruited in a way that generates lethal double-strand breaks, leading to apoptosis in rapidly dividing cancer cells (Marco & Gago, 2005). This mechanism makes the N2-guanine position a highly effective target for treating transcriptionally active malignancies such as soft tissue sarcomas and small cell lung cancer.
Covalent alkylation of the N2 position of guanine within the DNA minor groove (D'Incalci & Galmarini, 2010). This binding causes the DNA helix to bend toward the major groove, which disrupts the binding of transcription factors and interferes with the activity of RNA polymerase II. Furthermore, these adducts trap the nucleotide excision repair (NER) machinery, specifically the XPG and ERCC1 proteins, leading to the formation of lethal DNA double-strand breaks (Marco & Gago, 2005).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA guanine 2-amino group (N2-guanine).